Table 2 Pathological features of anti-GBM patients with MN

MN stage

II

II

III

Glomerular lesions

 Sclerosis (% of total G)

0

7.7 (2/26 G)

6.5 (2/31 G)

 Mild mesangial proliferation (% of total G)

0

15.4 (4/26 G)

16.1 (5/31 G)

Crescent components

 Cellular crescents (% of total G)

88.2 (15/17 G)

76.9 (20/26 G)

77.4 (24/31 G)

 Circumferential cellular crescent

58.8 (10/17 G)

23.1 (6/26 G)

70.9 (22/31 G)

 Fibrous-cellular crescents (% of total G)

29.4 (5/17 G)

3.8 (1/26 G)

0

 Fibrous crescents (% of total G)

0

0

0

Tubular-interstitial damage ^a

 Tubular atrophy

2

1

1

 Interstitial fibrosis

2

1

2

 Interstitial monocyte and lymphocyte infiltration

2

2

2